Reply to Comment on Detection of Mycotoxin in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605-617” by Mark J. Mendell †
Conflicts of Interest
References
- Brewer, J.H.; Thrasher, J.D.; Straus, D.C.; Madison, R.A.; Hooper, D. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins 2013, 5, 605–617. [Google Scholar] [CrossRef]
- Mendell, M.J. Comment on Detection of mycotoxins in patients with chronic fatigue syndrome, Toxins 2013, 5, 605–617. Toxins 2016, 11, 324. [Google Scholar]
- Wang, J.J.; Attia, J. Study designs in epidemiology and levels of evidence. Am. J. Ophthalmol. 2010, 149, 367–370. [Google Scholar] [CrossRef]
- Kempen, J. Appropriate use and reporting of Uncontrolled case series in the medical literature. Am. J. Ophthalmol. 2011, 151, 7–10. [Google Scholar] [CrossRef]
- Kooistra, B.; Dijkman, B.; Enhorn, T.A.; Bhandar, M. How to design a good case series. J. Bone Joint Surg. Am. 2009, 3, 21–26. [Google Scholar] [CrossRef]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Brewer, J.; Thrasher, J.D.; Hooper, D. Reply to Comment on Detection of Mycotoxin in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605-617” by Mark J. Mendell. Toxins 2016, 8, 325. https://doi.org/10.3390/toxins8110325
Brewer J, Thrasher JD, Hooper D. Reply to Comment on Detection of Mycotoxin in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605-617” by Mark J. Mendell. Toxins. 2016; 8(11):325. https://doi.org/10.3390/toxins8110325
Chicago/Turabian StyleBrewer, Joseph, Jack Dwayne Thrasher, and Dennis Hooper. 2016. "Reply to Comment on Detection of Mycotoxin in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605-617” by Mark J. Mendell" Toxins 8, no. 11: 325. https://doi.org/10.3390/toxins8110325